IBM Watson Turns Oncogenes Into Drug Targets

News   Aug 09, 2017 | Original story from Medical College of Georgia at Augusta University

 
IBM Watson Turns Oncogenes Into Drug Targets

Dr. Ravindra Kolhe, breast and molecular pathologist at the Medical College of Georgia at Augusta University

 
 
 

RELATED ARTICLES

Compliant-Ready LIMS Launched by LabVantage

News

LabVantage launches LIMS software that is the first GxP-compliant solution for data integrity and auditing, to help drug manufacturers conform to the FDA draft guidance on “Data Integrity and Compliance with CGMP.”

READ MORE

Forensic Evidence Shows Newfoundland was Populated Multiple Times by Distinct Groups

News

Analysis of tiny amounts of bone or teeth from ancient remains showed that groups of indigenous people from Newfoundland had distinct population histories.

READ MORE

Multi-tissue, Multi-individual Data Used to Identify Mechanisms of Gene Regulation

News

Developing a mechanistic model for how healthy bodies function and how certain diseases merge may now be possible.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE